- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 2, 2025 | 32.46M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $9.85M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $6.1M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $24.9M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $17.87M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $34M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $30.17M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $18.84M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $14.69M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $45.23M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $41.86M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 33.51M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 28.38M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $522.02K |
| Capex | Q3 2025 · Mar 31, 2024 | $57.76K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $1.59M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $14.13M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $13.96M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $7.33M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.03 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $5.08M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $14.9M |
| Net Income | Q3 2025 · Mar 31, 2024 | $76.3K |
| Net Income | Q3 2025 · Mar 31, 2024 | −$965.37K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $87.66K |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$1.43M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $5.48M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $14M |
| Revenue | Q3 2025 · Mar 31, 2024 | $12.12M |
| Revenue | Q3 2025 · Mar 31, 2024 | $32.49M |